CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study

被引：9

作者：

Niu, Jiahua ^{[1
,2
]}

Qiu, Huiying ^{[1
,2
]}

Xiang, Fang ^{[3
]}

Zhu, Lin ^{[3
]}

Yang, Jun ^{[1
,2
]}

Huang, Chongmei ^{[1
,2
]}

Zhou, Kun ^{[1
,2
]}

Tong, Yin ^{[1
,2
]}

Cai, Yu ^{[1
,2
]}

Dong, Baoxia ^{[1
,2
]}

Lu, Yuan ^{[3
]}

Sun, Xuedong ^{[3
]}

Wan, Liping ^{[1
,2
]}

Ding, Xueying ^{[2
]}

Wang, Haopeng ^{[4
]}

Song, Xianmin ^{[1
,2
]}

机构：

[1] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Dept Hematol, Shanghai, Peoples R China

[2] Shanghai Sci & Technol Comm STCSM, Engn Technol Res Ctr Cell Therapy & Clin Translat, Shanghai, Peoples R China

[3] Hrain Biotechnol, Shanghai, Peoples R China

[4] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China

来源：

BLOOD CANCER JOURNAL | 2023年 / 13卷 / 01期

基金：

国家重点研发计划;

关键词：

THERAPY; CD19;

D O I：

10.1038/s41408-023-00813-x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 50 条

[1] Enhanced efficacy of CD19/CD22 bispecific CAR-T cells with EAAAK linker on B-cell malignancies
Ma, Renyuxue
You, Fengtao
Tian, Shuaiyu
Zhang, Tingting
Tian, Xiaopeng
Xiang, Shufen
Wu, Hai
Yang, Nan
An, Gangli
Yang, Lin
EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (01) : 64 - 74
[2] CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial
Cordoba, Shaun
Onuoha, Shimobi
Thomas, Simon
Pignataro, Daniela Soriano
Hough, Rachael
Ghorashian, Sara
Vora, Ajay
Bonney, Denise
Veys, Paul
Rao, Kanchan
Lucchini, Giovanna
Chiesa, Robert
Chu, Jan
Clark, Liz
Fung, Mei Mei
Smith, Koval
Peticone, Carlotta
Al-Hajj, Muhammad
Baldan, Vania
Ferrari, Mathieu
Srivastava, Saket
Jha, Ram
Vargas, Frederick Arce
Duffy, Kevin
Day, William
Virgo, Paul
Wheeler, Lucy
Hancock, Jeremy
Farzaneh, Farzin
Domning, Sabine
Zhang, Yiyun
Khokhar, Nushmia Z.
Peddareddigari, Vijay G. R.
Wynn, Robert
Pule, Martin
Amrolia, Persis J.
NATURE MEDICINE, 2021, 27 (10) : 1797 - +
[3] CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial
Spiegel, Jay Y.
Patel, Shabnum
Muffly, Lori
Hossain, Nasheed M.
Oak, Jean
Baird, John H.
Frank, Matthew J.
Shiraz, Parveen
Sahaf, Bita
Craig, Juliana
Iglesias, Maria
Younes, Sheren
Natkunam, Yasodha
Ozawa, Michael G.
Yang, Eric
Tamaresis, John
Chinnasamy, Harshini
Ehlinger, Zach
Reynolds, Warren
Lynn, Rachel
Rotiroti, Maria Caterina
Gkitsas, Nikolaos
Arai, Sally
Johnston, Laura
Lowsky, Robert
Majzner, Robbie G.
Meyer, Everett
Negrin, Robert S.
Rezvani, Andrew R.
Sidana, Surbhi
Shizuru, Judith
Weng, Wen-Kai
Mullins, Chelsea
Jacob, Allison
Kirsch, Ilan
Bazzano, Magali
Zhou, Jing
Mackay, Sean
Bornheimer, Scott J.
Schultz, Liora
Ramakrishna, Sneha
Davis, Kara L.
Kong, Katherine A.
Shah, Nirali N.
Qin, Haiying
Fry, Terry
Feldman, Steven
Mackall, Crystal L.
Miklos, David B.
NATURE MEDICINE, 2021, 27 (08) : 1419 - +
[4] Dual targeting of CD19 and CD22 with bicistronic CAR-T cells in patients with relapsed/refractory large B-cell lymphoma
Roddie, Claire
Lekakis, Lazaros J.
Marzolini, Maria A. V.
Ramakrishnan, Aravind
Zhang, Yiyun
Hu, Yanqing
Peddareddigari, Vijay G. R.
Khokhar, Nushmia
Chen, Robert
Basilico, Silvia
Raymond, Meera
Vargas, Frederick Arce
Duffy, Kevin
Brugger, Wolfram
O'Reilly, Maeve A.
Wood, Leigh
Linch, David C.
Peggs, Karl S.
Bachier, Carlos
Budde, Elizabeth Lihua
Batlevi, Connie Lee
Bartlett, Nancy
Irvine, David
Tholouli, Eleni
Osborne, Wendy
Ardeshna, Kirit M.
Pule, Martin A.
BLOOD, 2023, 141 (20) : 2470 - 2482
[5] CD19 CAR T Cells for the Treatment of Pediatric Pre-B Cell Acute Lymphoblastic Leukemia
Pacenta, Holly L.
Laetsch, Theodore W.
John, Samuel
PEDIATRIC DRUGS, 2020, 22 (01) : 1 - 11
[6] Efficacy and Safety of CD28-or 4-1BB-Based CD19 CAR-T Cells in B Cell Acute Lymphoblastic Leukemia
Zhao, Xiangyu
Yang, Junfang
Zhang, Xian
Lu, Xin-An
Xiong, Min
Zhang, Jianping
Zhou, Xiaosu
Qi, Feifei
He, Ting
Ding, Yanping
Hu, Xuelian
De Smet, Floris
Lu, Peihua
Huang, Xiaojun
MOLECULAR THERAPY-ONCOLYTICS, 2020, 18 : 272 - 281
[7] Engineering Novel CD19/CD22 Dual-Target CAR-T Cells for Improved Anti-Tumor Activity
Zeng, Wanying
Zhang, Qing
Zhu, Yangmin
Ou, Ruiming
Peng, Liang
Wang, Baolei
Shen, Huijuan
Liu, Zhi
Lu, Lisheng
Zhang, Pumin
Liu, Shuang
CANCER INVESTIGATION, 2022, 40 (03) : 282 - 292
[8] A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia
Masih, Katherine E.
Gardner, Rebecca A.
Chou, Hsien-Chao
Abdelmaksoud, Abdalla
Song, Young K.
Mariani, Luca
Gangalapudi, Vineela
Gryder, Berkley E.
Wilson, Ashley L.
Adebola, Serifat O.
Stanton, Benjamin Z.
Wang, Chaoyu
Milewski, David
Kim, Yong Yean
Tian, Meijie
Cheuk, Adam Tai -Chi
Wen, Xinyu
Zhang, Yue
Altan-Bonnet, Gregoire
Kelly, Michael C.
Wei, Jun S.
Bulyk, Martha L.
Jensen, Michael C.
Orentas, Rimas J.
Khan, Javed
BLOOD ADVANCES, 2023, 7 (15) : 4218 - 4232
[9] Bispecific CAR-T cells targeting CD19/20 in patients with relapsed or refractory B cell non-Hodgkin lymphoma: a phase I/II trial
Wang, Lixin
Fang, Chuling
Kang, Qingzheng
Huang, Wenfa
Chen, Ziren
Zhao, Weiqiang
Wang, Lei
Wang, Yiran
Tan, Kun
Guo, Xiao
Xu, Yuanyuan
Wang, Shuhong
Wang, Lijun
Qiao, Jingqiao
Tang, Zhixiong
Yu, Chuan
Xu, Yang
Li, Yisheng
Yu, Li
BLOOD CANCER JOURNAL, 2024, 14 (01):
[10] A systematic review and meta-analysis of CD22 CAR T-cells alone or in combination with CD19 CAR T-cells
Fergusson, Nathan J.
Adeel, Komal
Kekre, Natasha
Atkins, Harold
Hay, Kevin A.
FRONTIERS IN IMMUNOLOGY, 2023, 14

← 1 2 3 4 5 →